House Bill Would Revamp Compounding Pharmacy Oversight
A bipartisan group of U.S. House of Representatives lawmakers on Thursday introduced a new bill aimed at improving U.S. Food and Drug Administration oversight of large drug compounding facilities like the...To view the full article, register now.
Already a subscriber? Click here to view full article